Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4523950 Target Snapshot

Dihydroorotate dehydrogenase (quinone), mitochondrial · SINGLE PROTEIN · Schistosoma mansoni

35Compounds
11Assays
2Approved Drugs
32.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt G4VFD7. Use UniProt G4VFD7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt G4VFD7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Dihydroorotate dehydrogenase (quinone), mitochondrial as ChEMBL target CHEMBL4523950, mapped to UniProt G4VFD7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Dihydroorotate dehydrogenase (quinone), mitochondrial
SINGLE PROTEIN · Schistosoma mansoni
As of 2026-09-14
ChEMBL target ID
CHEMBL4523950
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
G4VFD7
Dihydroorotate dehydrogenase (quinone), mitochondrial
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Dihydroorotate dehydrogenase (quinone), mitochondrial is the right protein anchor across sources, using UniProt G4VFD7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDihydroorotate dehydrogenase (quinone), mitochondrial
UniProt AccessionG4VFD7
Component TypeProtein
Sequence Length379 aa

Dihydroorotate dehydrogenase (quinone), mitochondrial

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Dihydroorotate dehydrogenase (quinone), mitochondrial, mapped to UniProt G4VFD7. Sequence length is 379 aa.

Mapped IDG4VFD7
Review nameDihydroorotate dehydrogenase (quinone), mitochondrial
OrganismSchistosoma mansoni
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5032.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL15193 7.72 IC50 19.0 Preclinical
CHEMBL4540838 7.72 IC50 19.0 Preclinical
CHEMBL155771 7.64 IC50 23.0 Preclinical
CHEMBL4452960 7.11 IC50 78.0 Preclinical
CHEMBL4472078 6.96 IC50 111.0 Preclinical
CHEMBL4457147 6.89 IC50 129.0 Preclinical
CHEMBL4560384 6.73 IC50 185.0 Preclinical
CHEMBL4474026 6.64 IC50 227.0 Preclinical
CHEMBL4527976 6.43 IC50 375.0 Preclinical
CHEMBL1450 6.37 IC50 430.0 Approved
Distribution

pChEMBL Value Distribution

4
5.0
4
5.5
6
6.0
4
6.5
1
7.0
3
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ATOVAQUONE
CHEMBL1450
Approved 1992
Assay Landscape

Assay Landscape

11
Total Assays
29
Tested Compounds
1
Assay Types
Binding — 11 assays, 29 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 11 29 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine